Abstract
In the last decades, gasotransmitters have gained attention for their crucial role in pathophysiological and cellular functions. Gasotransmitters are gaseous mediators of the cellular signaling and biological responses from one end to the other. The isoform of these gaseous signaling molecules includes NO (nitric oxide), CO (carbon monoxide), and H2S (hydrogen sulphide), collectively called gasotransmitters. The diverse role of these gasotransmitters in cell and molecular biology as well as biochemical processing has been well validated through several scientific and clinical studies. The biosynthesis, interaction, and movement of gasotransmitters inside the cellular systems are critical especially in terms of their pharmacological response. These gaseous molecules are very toxic and hazardous to human health at higher concentrations but at lower levels they may be considered as therapeutic agents. They can easily diffuse through all the cell membrane and act on their targets for generating pharmacological responses. Due to its gaseous nature, the cellular interactions at the target sites are complex and make it a critical task for researchers to understand. The mode of action and molecular pathways are still under the exploratory phase. Apart from their toxic nature, there are several pharmacological activities such as cardioprotective, antihypertensive, smooth muscle relaxant, vasodilator, antithrombotic, antitumor, etc. that have been reported for these gaseous molecules. This gaseous family has become a promising area for multidisciplinary research in order to establish their importance in relation to disease and health. The perspective of these gasotransmitters is required to validate the clinical translational and future investigation following clear cut understanding of their pharmacological properties. This book chapter deals with the biosynthesis, pharmacological application and clinical utility of gaseous molecules mainly NO and CO.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD:
-
Alzheimer’s Disease
- ARDS:
-
Acute respiratory distress syndrome
- BP:
-
Blood pressure
- C/EBP:
-
CCAATT-enhancer-binding protein
- CaM:
-
Calcium-binding messenger protein calmodulin
- cGMP:
-
3,5-Cyclic guanosine monophosphate
- CO:
-
Carbon monoxide
- CO2 :
-
Carbon dioxide
- CoHb:
-
Carboxyhemoglobin
- COPD:
-
Chronic obstructive pulmonary disease
- CORMs:
-
CO releasing molecules
- CP:
-
Cisplatin
- CVD:
-
Cardiovascular disease
- CYT2E1:
-
Cytochrome P450 2E
- DCM:
-
Dichloromethane
- ED:
-
Erectile dysfunction
- EDHF:
-
Endothelium-derived hyper polarizing factor
- EDRF:
-
Endothelium-derived relaxing factor
- ENOG:
-
European Network on Gasotransmitters
- eNOS:
-
Endothelial NOS
- ER:
-
Endoplasmic reticulum
- GTN:
-
Glyceryltrinitrate
- GTP:
-
Guanosine5-triphosphate
- GTT:
-
Glucose tolerance test
- H2S:
-
Hydrogen sulfide
- Hb:
-
Hemoglobin
- HIF:
-
Hypoxia inducible factor
- HO:
-
Heme oxygenase
- HO-1:
-
Heme oxygenase-1
- HO-2:
-
Heme oxygenase-2
- HUVECs:
-
Human umbilical vein endothelial cells
- iNOS:
-
Inducible NOS
- MAPK:
-
Mitogen activated protein kinases
- MI:
-
Myocardial infarction
- nNOS:
-
Neuronal NOS
- NO:
-
Nitric oxide
- NOS:
-
Nitric oxide synthase
- O2 _ :
-
Peroxide radical
- OH• :
-
Hydroxyl radical
- ONOO:
-
Peroxynitrite
- PAH:
-
Pulmonary arterial hypertension
- PI3K:
-
Phosphatidyl inositol 3-kinase
- PI3K:
-
Phosphatidylinositol-3 kinase
- PKC:
-
Protein kinase C
- PPARc:
-
Peroxisome proliferator-activated receptor-c
- RAS:
-
Renin–angiotensin system
- ROS:
-
Reactive oxygen species
- S• :
-
Superoxide radical
- sGC:
-
Soluble guanylatecyclase enzyme
- SiRNA:
-
Small interfering RNA
- TB:
-
Tuberculosis
- TNF:
-
Tumor necrosis factor
- VEGF:
-
Vascular endothelial growth factor
- VSMC:
-
Vascular smooth muscle cell
References
Abdelall EKA, Abdelhamid AO, Azouz AA (2017) Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids. Bioorg Med Chem Lett 27(18):4358–4369
Abraham NG, Kappas A (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60:79–127
Abraham NG, Jiang H, Balazy M, Goodman AI (2003) Methods for measurements of heme oxygenase (HO) isoforms-mediated synthesis of carbon monoxide and HO-1 and HO-2 proteins. Methods Mol Med 86:399–411
Adela R, Nethi SK, Bagul PK, Barui AK, Mattapally S, Kuncha M, Patra CR, Reddy PN, Banerjee SK (2015) Hyperglycaemia enhances nitric oxide production in diabetes: a study from south Indian patients. PLoS One 10(4):e0125270
Akter F, Coghlan G, de Mel A (2016) Nitric oxide in paediatric respiratory disorders: novel interventions to address associated vascular phenomena? Ther Adv Cardiovasc Dis 10(4):256–270
Al Omar S, Salama H, Al HM, Al RH, Bunahia M, El Kasem W, Siddiqui FJ, Dilawar M, Yassin H, Masud F, Mohamed A, Mansour A (2016) Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study. J Neonatal Perinatal Med 9(3):251–259
Alam J, Wicks C, Stewart D, Gong P, Touchard C, Otterbein L, Choi A, Burow M, Tou J.-s. (2000) Mechanism of Heme Oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of OF p38 kinase and Nrf2 transcription factor. J Biol Chem 275(36):27694–27702
Allen TA, Root WS (1957) Partition of carbon monoxide and oxygen between air and whole blood of rats, dogs and men as affected by plasma pH. J Appl Physiol 10(2):186–190
Amsel SDJ, Kevin J, Soden KJ, Sielken RL Jr, Valdez-Flora C (2001) Observed versus predicted carboxyhemoglobin levels in cellulose triacetate workers exposed to methylene chloride. Am J Ind Med 40(2):180–191
Andreadou I, Iliodromitis EK, Rassaf T, Schulz R, Papapetropoulos A, Ferdinandy P (2015) The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning. Br J Pharmacol 172(6):1587–1606
Antosova M, Mokra D, Pepucha L, Plevkova J, Buday T, Sterusky M, Bencova A (2017) Physiology of nitric oxide in the respiratory system. Physiol Res 66(Supplementum 2):S159–S172
Archakov AI, Karuzina II, Petushkova N, Lisitsa AV, Zgoda V (2002) Production of carbon monoxide by cytochrome P450 during iron-dependent lipid peroxidation. Toxicol In Vitro 16(1):1–10
Arzumanian V, Stankevicius E, Laukeviciene A, Kevelaitis E (2003) Mechanisms of nitric oxide synthesis and action in cells. Medicina (Kaunas) 39(6):535–541
Austin SA, Katusic ZS (2016) Loss of endothelial nitric oxide synthase promotes p25 generation and tau phosphorylation in a murine model of Alzheimer’s disease. Circ Res 119(10):1128–1134
Bagul A, Hosgood S, Kaushik M, Nicholson ML (2008) Carbon monoxide protects against ischemia-reperfusion injury in an experimental model of controlled nonheartbeating donor kidney. Transplantation 85(4):576–581
Baran CP, Zeigler MM, Tridandapani S, Marsh CB (2004) The role of ROS and RNS in regulating life and death of blood monocytes. Curr Pharm Des 10(8):855–866
Basudhar D, Somasundaram V, de Oliveira GA, Kesarwala A, Heinecke JL, Cheng RY, Glynn SA, Ambs S, Wink DA, Ridnour LA (2017) Nitric oxide Synthase-2-derived nitric oxide drives multiple pathways of breast Cancer progression. Antioxid Redox Signal 26(18):1044–1058
Bhat KH, Srivastava S, Kotturu SK, Ghosh S, Mukhopadhyay S (2017) The PPE2 protein of Mycobacterium tuberculosis translocates to host nucleus and inhibits nitric oxide production. Sci Rep 7:39706
Boehning D, Moon C, Sharma S, Hurt KJ, Hester LD, Ronnett GV, Shugar D, Snyder SH (2003) Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase-2. Neuron 40(1):129–137
Bohlen HG (2015) Nitric oxide and the cardiovascular system. Compr Physiol 5(2):808–823
Botros FT, Navar LG (2006) Interaction between endogenously produced carbon monoxide and nitric oxide in regulation of renal afferent arterioles. Am J Phys Heart Circ Phys 291(6):H2772–H2778
Braverman J, Stanley SA (2017a) Nitric oxide modulates macrophage responses to Mycobacterium tuberculosis infection through activation of HIF-1alpha and repression of NF-kappaB. J Immunol 199(5):1805–1816
Braverman J, Stanley SA (2017b) Nitric oxide modulates macrophage responses to Mycobacterium tuberculosis infection through activation of HIF-1alpha and repression of NF-kappaB. J Immunol 199(5):1805–1816
Burnett AL (2006) The role of nitric oxide in erectile dysfunction: implications for medical therapy. J Clin Hypertens (Greenwich) 8(12 Suppl 4):53–62
Cartledge J, Minhas S, Eardley I (2001) The role of nitric oxide in penile erection. Expert Opin Pharmacother 2(1):95–107
Cepinskas G, Katada K, Bihari A, Potter RF (2008) Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am J Physiol Gastrointest Liver Physiol 294(1):G184–G191
Chen K, Maines MD (2000) Nitric oxide induces heme oxygenase-1 via mitogen-activated protein kinases ERK and p38. Cell Mol Biol (Noisy-le-Grand) 46(3):609–617
Chen B, Guo L, Fan C, Bolisetty S, Joseph R, Wright MM, Agarwal A, George JF (2009) Carbon monoxide rescues Heme Oxygenase-1-deficient mice from arterial thrombosis in allogeneic aortic transplantation. Am J Pathol 175(1):422–429
Cheng Y, Rong J (2017) Therapeutic potential of Heme Oxygenase-1/carbon monoxide system against ischemia-reperfusion injury. Curr Pharm Des 23(26):3884–3898
Chin BY, Jiang G, Wegiel B, Wang HJ, MacDonald T, Zhang XC, Gallo D, Cszimadia E, Bach FH, Lee PJ, Otterbein LE (2007) Hypoxia-inducible factor 1α stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci 104(12):5109–5114
Chinta KC, Saini V, Glasgow JN, Mazorodze JH, Rahman MA, Reddy D, Lancaster JR Jr, Steyn AJ (2016a) The emerging role of gasotransmitters in the pathogenesis of tuberculosis. Nitric Oxide 59:28–41
Chinta KC, Saini V, Glasgow JN, Mazorodze JH, Rahman MA, Reddy D, Lancaster JR Jr, Steyn AJ (2016b) The emerging role of gasotransmitters in the pathogenesis of tuberculosis. Nitric Oxide 59:28–41
Choi YK (2018) Role of carbon monoxide in neurovascular repair processing. Biomol Ther (Seoul) 26(2):93–100
Choi BM, Pae HO, Kim YM, Chung HT (2003) Nitric oxide-mediated cytoprotection of hepatocytes from glucose deprivation-induced cytotoxicity: involvement of heme oxygenase-1. Hepatology 37(4):810–823
Cifuentes D, Poittevin M, Bonnin P, Ngkelo A, Kubis N, Merkulova-Rainon T, Levy BI (2017) Inactivation of nitric oxide synthesis exacerbates the development of Alzheimer disease pathology in APPPS1 mice (amyloid precursor protein/Presenilin-1). Hypertension 70(3):613–623
Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, Foresti R, Motterlini R (2003) Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93(2):e2–e8
Coburn RF (1970) The carbon monoxide body stores. Ann N Y Acad Sci U S A 174(1):11–22
Coburn RF, Mayers LB (1971) Myoglobin O2 tension determined from measurement of carboxymyoglobin in skeletal muscle. Am J Phys 220(1):66–74
Coburn RF, Blakemore WS, Forster RE (1963a) Endogenous carbon monoxide production in man. J Clin Invest 42:1172–1178
Coburn RF, Blakemore WS, Forster RE (1963b) Endogenous carbon monoxide production in man. J Clin Invest 42:1172–1178
Csongradi E, Juncos LA, Drummond HA, Vera T, Stec DE (2012) Role of carbon monoxide in kidney function: is a little carbon monoxide good for the kidney? Curr Pharm Biotechnol 13(6):819–826
Dallas ML, Scragg JL, Peers C (2009) Inhibition of L-type Ca(2+) channels by carbon monoxide. Adv Exp Med Biol 648:89–95
Dashwood MR, Crump A, Shi-Wen X, Loesch A (2011) Identification of neuronal nitric oxide synthase (nNOS) in human penis: a potential role of reduced neuronally-derived nitric oxide in erectile dysfunction. Curr Pharm Biotechnol 12(9):1316–1321
Divakaran S, Loscalzo J (2017) The role of nitroglycerin and other nitrogen oxides in cardiovascular therapeutics. J Am Coll Cardiol 70(19):2393–2410
Doroszko A, Dobrowolski P, Radziwon-Balicka A, Skomro R (2018) New insights into the role of oxidative stress in onset of cardiovascular disease. Oxidative Med Cell Longev 2018:9563831
Durante W, Christodoulides N, Cheng K, Peyton KJ, Sunahara RK, Schafer AI (1997) CAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. Am J Physiol 273(1 Pt 2):H317–H323
Fabiani J-N, Achouh PE, Simonet S, Verbeuren TJ (2008) Carbon monoxide induces relaxation of human internal thoracic and radial arterial grafts. Interact Cardiovasc Thorac Surg 7(6):959–962
Fadel PJ (2017) Nitric oxide and cardiovascular regulation: beyond the endothelium. Hypertension 69(5):778–779
Farrugia G, Szurszewski JH (2014) Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules in the gastrointestinal tract. Gastroenterology 147(2):303–313
Fleissner F, Thum T (2011) Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction. Antioxid Redox Signal 15(4):933–948
Fordjour PA, Wang Y, Shi Y, Agyemang K, Akinyi M, Zhang Q, Fan G (2015) Possible mechanisms of C-reactive protein mediated acute myocardial infarction. Eur J Pharmacol 760:72–80
Foresti R, Hammad J, Clark J, Johnson TR, Mann BE, Friebe A, Green C, Motterlini R (2004) Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 142(3):453–460
Forstermann U (2010) Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459(6):923–939
Forstermann U, Sessa WC (2012) (2012). Nitric oxide synthases: regulation and function. Eur Heart J 33(7):829–837
Forstermann U, Xia N, Li H (2017) Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res 120(4):713–735
Freitas A, Alves-Filho JC, Secco DD, Neto AF, Ferreira SH, Barja-Fidalgo C, Cunha FQ (2006) Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br J Pharmacol 149(4):345–354
Fujimoto H, Ohno M, Ayabe S, Kobayashi H, Ishizaka N, Kimura H, Yoshida K-I, Nagai R (2004) Carbon monoxide protects against cardiac ischemia – reperfusion injury in vivo via MAPK and Akt – eNOS pathways. Arterioscler Thromb Vasc Biol 24(10):1848–1853
Fujisaki N, Kohama K, Nishimura T, Yamashita H, Ishikawa M, Kanematsu A, Yamada T, Lee S, Yumoto T, Tsukahara K, Kotani J, Nakao A (2016) Donor pretreatment with carbon monoxide prevents ischemia/reperfusion injury following heart transplantation in rats. Med Gas Res 6(3):122–129
Garcia-Mata C, Lamattina L (2013) Gasotransmitters are emerging as new guard cell signaling molecules and regulators of leaf gas exchange. Plant Sci 201-202:66–73
Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, Noguchi M (2004) Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene. https://doi.org/10.1016/j.gene.2004.04.002
Heinemann SH, Hoshi T, Westerhausen M, Schiller A (2014) Carbon monoxide--physiology, detection and controlled release. Chem Commun (Camb) 50(28):3644–3660
Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT (2013) NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493(7434):674–678
Henningsson R, Alm P, Ekström P, Lundquist I (1999) Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release - A biochemical, immunohistochemical, and confocal microscopic study. Diabetes 48(1):66–76
Hettiarachchi N, Dallas M, Al-Owais M, Griffiths H, Hooper N, Scragg J, Boyle J, Peers C (2014) Heme oxygenase-1 protects against Alzheimer’s amyloid-beta(1-42)-induced toxicity via carbon monoxide production. Cell Death Dis 5:e1569
Hou S, Xu R, Heinemann SH, Hoshi T (2008) The RCK1 high-affinity Ca2+ sensor confers carbon monoxide sensitivity to Slo1 BK channels. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.0800304105
Immenschuh S, Kietzmann T, Hinke V, Wiederhold M, Katz N, Muller-Eberhard U (1998) The rat heme oxygenase-1 gene is transcriptionally induced via the protein kinase A signaling pathway in rat hepatocyte cultures. Mol Pharmacol 53:483–491
Johnson TR, Mann BE, Clark J, Foresti R, Green C, Motterlini R (2003) Metal carbonyls: a new class of pharmaceuticals? Angew Chem Int Ed Engl 42(32):3722–3729
Johnson F, Johnson RA, Durante W, Jackson K, Stevenson BK, Peyton KJ (2006) Metabolic syndrome increases endogenous carbon monoxide production to promote endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 290(3):R601–R608
Katusic ZS, Austin SA (2014) Endothelial nitric oxide: protector of a healthy mind. Eur Heart J 35(14):888–894
Keshet R, Erez A (2018) Arginine and the metabolic regulation of nitric oxide synthesis in cancer. Dis Model Mech 11(8):dmm033332
Kim HS, Loughran PA, Rao J, Billiar TR, Zuckerbraun BS (2008) Carbon monoxide activates NF-kappaB via ROS generation and Akt pathways to protect against cell death of hepatocytes. Am J Physiol Gastrointest Liver Physiol 295(1):G146–G152
Kobayashi A, Ishikawa K, Matsumoto H, Kimura S, Kamiyama Y, Maruyama Y (2007) Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II - induced cardiac hypertrophy. Hypertension 50(6):1040–1048
Kolluru GK, Shen X, Yuan S, Kevil CG (2017) Gasotransmitter heterocellular signaling. Antioxid Redox Signal 26(16):936–960
Kovacevic Z, Sahni S, Lok H, Davies MJ, Wink DA, Richardson DR (2017) Regulation and control of nitric oxide (NO) in macrophages: protecting the “professional killer cell” from its own cytotoxic arsenal via MRP1 and GSTP1. Biochim Biophys Acta Gen Subj. 1861(5 Pt A):995–999
Kubic VL, Anders MW (1978) Metabolism of dihalomethanes to carbon monoxide—III: studies on the mechanism of the reaction. Biochem Pharmacol 27(19):2349–2355
Lakkisto P, Kytö V, Forsten H, Siren J-M, Segersvärd H, Voipio-Pulkki L-M, Laine M, Pulkki K, Tikkanen I (2010) Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1α, SDF-1α and VEGF-B, vol 635, pp 156–164
Lamon BD, Zhang FF, Puri N, Brodsky SV, Goligorsky MS, Nasjletti A (2009) Dual pathways of carbon monoxide–mediated vasoregulation. Circ Res 105(8):775–783
Lee T-S, Tsai H-L, Chau L-Y (2003) Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Δ12,14-prostaglandin J2. J Biol Chem 278:19325–19330
Lee M, Rey K, Besler K, Wang C, Choy J (2017) Immunobiology of nitric oxide and regulation of inducible nitric oxide synthase. Results Probl Cell Differ 62:181–207
Leffler CW, Nasjletti A, Yu C, Johnson RA, Fedinec AL, Walker N (1999) Carbon monoxide and cerebral microvascular tone in newborn pigs. Am J Phys Heart Circ Phys 276(5):H1641–H1646
Li VG, Sacerdoti D, Sangras B, Vanella A, Mezentsev A, Scapagnini G, Falck J, Abraham NG (2005) Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells. Antioxid Redox Signal. https://doi.org/10.1089/ars.2005.7.704
Li A, Xi Q, Umstot ES, Bellner L, Schwartzman ML, Jaggar JH, Leffler CW (2008) Astrocyte-derived CO is a diffusible messenger that mediates glutamate-induced cerebral arteriolar dilation by activating smooth muscle cell KCa channels. Circ Res 102(2):234–241
Li L, Hsu A, Moore PK (2009) Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation—a tale of three gases! Pharmacol Ther. https://doi.org/10.1016/j.pharmthera.2009.05.005
Li H, Horke S, Forstermann U (2014) Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis 237(1):208–219
Lin HH, Lai SC, Chau LY (2011) Heme oxygenase-1/carbon monoxide induces vascular endothelial growth factor expression via p38 kinase-dependent activation of Sp1. J Biol Chem 286(5):3829–3838
Ling K, Men F, Wang W-C, Zhou Y-Q, Zhang H-W, Ye D-W (2017) Carbon monoxide and its controlled release: therapeutic application, detection, and development of carbon monoxide releasing molecules (CORMs). J Med Chem. https://doi.org/10.1021/acs.jmedchem.6b01153
Lowenstein CJ, Dinerman JL, Snyder SH (1994) Nitric oxide: a physiologic messenger. Ann Intern Med 120(3):227–237
Luo S, Lei H, Qin H, Xia Y (2014) Molecular mechanisms of endothelial NO synthase uncoupling. Curr Pharm Des 20(22):3548–3553
MacMicking J, Xie QW, Nathan C (1997a) Nitric oxide and macrophage function. Annu Rev Immunol 15:323–350
MacMicking J, Xie QW, Nathan C (1997b) Nitric oxide and macrophage function. Annu Rev Immunol 15:323–350
McCoubrey WK Jr, Huang TJ, Maines MD (1997) Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247(2):725–732
Miller MR, Megson IL (2007) Recent developments in nitric oxide donor drugs. Br J Pharmacol 151(3):305–321
Mir JM, Maurya R (2018) A gentle introduction to gasotransmitters with special reference to nitric oxide: biological and chemical implications. Rev Inorg Chem 38(4):193–220
Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329(27):2002–2012
Motterlini R, Foresti R (2017) Biological signaling by carbon monoxide and carbon monoxide-releasing molecules. Am J Physiol Cell Physiol 312(3):C302–C313
Motterlini R, Otterbein LE (2010) The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9(9):728–743
Munzel T, Daiber A (2018) Inorganic nitrite and nitrate in cardiovascular therapy: A better alternative to organic nitrates as nitric oxide donors? Vasc Pharmacol 102:1–10
Nagpure BV, Bian JS (2016) Interaction of hydrogen sulfide with nitric oxide in the cardiovascular system. Oxidative Med Cell Longev 2016:6904327
Nakao A, Huang C-S, Stolz DB, Wang Y, Franks J, Tochigi N, R Billiar T, Toyoda Y, Tzeng E, R McCurry K (2011) Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts. Cardiovasc Res. https://doi.org/10.1093/cvr/cvq298
Naseem KM (2005) The role of nitric oxide in cardiovascular diseases. Mol Asp Med 26(1–2):33–65
Ndisang JF, Tabien HEN, Wang R (2004) Carbon monoxide and hypertension. J Hypertens 22(6):1057–1074
Neilly PJ, Kirk SJ, Gardiner KR, Rowlands BJ (1994) The L-arginine/nitric oxide pathway--biological properties and therapeutic applications. Ulster Med J 63(2):193–200
Nizamutdinova IT, Kim YM, Kim HJ, Seo HG, Lee JH, Chang KC (2009) Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-γ activations in endothelial cells. Atherosclerosis 207(2):405–411
Nobre LS, Seixas JD, Romão CC, Saraiva LM (2007) Antimicrobial action of carbon monoxide-releasing compounds. Antimicrob Agents Chemother 51(12):4303–4307
Okuyama H, Yonetani M, Uetani Y, Nakamura H (2001) End-tidal carbon monoxide is predictive for neonatal non-hemolytic hyperbilirubinemia. Pediatr Int 43(4):329–333
Olah G, Modis K, Toro G, Hellmich MR, Szczesny B, Szabo C (2018) Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation. Biochem Pharmacol 149:186–204
Omar SA, Webb AJ, Lundberg JO, Weitzberg E (2016) Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases. J Intern Med 279(4):315–336
Owens EO (2010) Endogenous carbon monoxide production in disease. Clin Biochem 43(15):1183–1188
Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, Chora Â, Rodrigues CD, Grégoire I, Cunha-Rodrigues M, Portugal S, P Soares M, Mota M (2007) Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med. 13(6):703–710
Papapetropoulos A, Foresti R, Ferdinandy P (2015) Pharmacology of the ‘gasotransmitters’ NO, CO and H2S: translational opportunities. Br J Pharmacol 172(6):1395–1396
Paredi P, Biernacki W, Invernizzi G, Kharitonov SA, Barnes PJ (1999) Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: A new test for monitoring the disease? Chest 116(4):1007–1011
Paul BD, Snyder SH (2018a) Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem Pharmacol 149:101–109
Paul BD, Snyder SH (2018b) Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem Pharmacol 149:101–109
Piazza M, Dieckmann T, Guillemette JG (2018) Investigation of the structure and dynamic of calmodulin-nitric oxide synthase complexes using NMR spectroscopy. Front Biosci (Landmark Ed) 23:1902–1922
Pitsikas N (2015) The role of nitric oxide in the object recognition memory. Behav Brain Res 285:200–207
Polhemus DJ, Lefer DJ (2014) Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ Res 114(4):730–737
Poulos TL, Li H (2017) Nitric oxide synthase and structure-based inhibitor design. Nitric Oxide 63:68–77
Queiroga C, Almeida A, Alves P, Brenner C, Vieira H (2011) Carbon monoxide prevents hepatic mitochondrial membrane permeabilization. BMC Cell Biol 12:10
Quillon A, Fromy B, Debret R (2015) Endothelium microenvironment sensing leading to nitric oxide mediated vasodilation: a review of nervous and biomechanical signals. Nitric Oxide 45:20–26
Raman K, Barbato JE, Ifedigbo E, Ozanich BA, Zenati M, Otterbein L, Tzeng E (2006) Inhaled carbon monoxide inhibits intimal hyperplasia and provides added benefit with nitric oxide. J Vasc Surg. 44(1):151–158
Ramlawi B, Scott JR, Feng J, Mieno S, Raman KG, Gallo D, Csizmadia E, Yoke CB, Bach FH, Otterbein LE, Sellke FW (2007) Inhaled carbon monoxide prevents graft-induced intimal hyperplasia in swine. J Surg Res 138(1):121–127
Riddell DR, Owen JS (1999) Nitric oxide and platelet aggregation. Vitam Horm 57:25–48
Rochette L, Lorin J, Zeller M, Guilland JC, Lorgis L, Cottin Y, Vergely C (2013) Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Pharmacol Ther 140(3):239–257
Ryter SW, Choi AM (2013) Carbon monoxide: present and future indications for a medical gas. Korean J Intern Med 28(2):123–140
Shahrbaf MA, Mahjoob MP, Khaheshi I, Akbarzadeh MA, Barkhordari E, Naderian M, Tajrishi FZ (2018) The role of air pollution on ST-elevation myocardial infarction: A narrative mini review. Futur Cardiol 14(4):301–306
Shefa U, Yeo SG, Kim MS, Song IO, Jung J, Jeong NY, Huh Y (2017) Role of gasotransmitters in oxidative stresses, neuroinflammation, and neuronal repair. Biomed Res Int. https://doi.org/10.1155/2017/1689341. Epub 2017 Mar 12
Simon T, Anegon I, Blancou P (2011) Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancer. Immunotherapy 3(4 Suppl):15–18
Sjostrand T (1952) The formation of carbon monoxide by the decomposition of haemoglobin in vivo. Acta Physiol Scand 26(4):338–344
Socco S, Bovee RC, Palczewski MB, Hickok JR, Thomas DD (2017) Epigenetics: the third pillar of nitric oxide signaling. Pharmacol Res 121:52–58
Stein A, Guo Y, Tan W, Wu W-J, Zhu X, Li Q, Luo C, Dawn B, Johnson TR, Motterlini R, Bolli R (2005) Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 38(1):127–134
Stevenson DK, Vreman HJ, Oh W, Fanaroff AA, Wright LL, Lemons JA, Verter J, Shankaran S, Tyson JE, Korones SB et al (1994) Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clin Chem 40(10):1934–1939
Stewart RD, Fisher TN, Hosko MJ, Peterson JE, Baretta ED, Dodd HC (1972) Carboxyhemoglobin elevation after exposure to dichloromethane. Science 176(4032):295–296
Sukmansky OI, Reutov VP (2016) Gasotransmitters: physiological role and involvement in the pathogenesis of the diseases. Usp Fiziol Nauk 47(3):30–58
Szabo C (2010) Gaseotransmitters: new frontiers for translational science. Sci Transl Med 2(59):59ps54. https://doi.org/10.1126/scitranslmed.3000721
Takehito T, Yoshifumi M (1988) Metabolism of dichloromethane and the subsequent binding of its product, carbon monoxide, to cytochrome P-450 in perfused rat liver. Toxicol Lett 40(1):93–96
Tayem Y, Johnson TR, Mann BE, Green CJ, Motterlini R (2006) Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. Am J Physiol Renal Physiol 290(4):F789–F794
Tenhunen R, Marver HS, Schmid R (1968) The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 61(2):748–755
Terry C, Clikeman JA, Hoidal JR, Callahan KS (1999) TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. Am J Physiol 276(5):H1493–H1501
Thom SR (1990) Carbon monoxide-mediated brain lipid peroxidation in the rat. J Appl Physiol 68(3):997–1003
Traub O, Van Bibber R (1995) Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications. West J Med 162(5):439–445
Truss NJ, Warner T (2011a) Gasotransmitters and platelets. Pharmacol Ther 132(2):196–203
Truss NJ, Warner TD (2011b) Gasotransmitters and platelets. Pharmacol Ther 132(2):196–203
Untereiner A, Wu L, Wang R (2012) The role of carbon monoxide as a gasotransmitter. In: Hermann A, Sitdikova G, Weiger T (eds) Gasotransmitters: physiology and pathophysiology, pp 37–70
Urquhart P, Rosignoli G, Cooper D, Motterlini R, Perretti M (2007) Carbon monoxide-releasing molecules modulate leukocyte-endothelial interactions under flow. J Pharmacol Exp Ther 321(2):656–662
van den Born JC, Hammes HP, Greffrath W, van Goor H, Hillebrands JL, DFG GRK International Research Training Group 1874 Diabetic Microvascular Complications (DIAMICOM) (2016) Gasotransmitters in vascular complications of diabetes. Diabetes 65(2):331–345
Van Landeghem L, Laleman W, Van der Elst I, Zeegers M, Van Pelt J, Cassiman D, Nevens F (2009) Carbon monoxide produced by intrasinusoidally located haem-oxygenase-1 regulates the vascular tone in cirrhotic rat liver. Liver Int 29(5):650–660
Vanhoutte PM, Gao Y (2013) Beta blockers, nitric oxide, and cardiovascular disease. Curr Opin Pharmacol 13(2):265–273
Vannacci A, Di Felice A, Giannini L, Marzocca C, Pierpaolo S, Zagli G, Masini E, Mannaioni PF (2004) The effect of carbon monoxide releasing molocule on the immunological activation of guinea-pig mast cells and human basophils. Inflamm Res; 53 Suppl 1:S9–S10
Varadi J, Lekli I, Juhasz B, Bácskay I, Szabo G, Gesztelyi R, Szendrei L, Varga E, Bak I, Foresti R, Motterlini R, Tosaki A (2007) Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery, vol 80, pp 1619–1626
Venketaraman V, Talaue MT, Dayaram YK, Peteroy-Kelly MA, Bu W, Connell ND (2003) Nitric oxide regulation of L-arginine uptake in murine and human macrophages. Tuberculosis (Edinb) 83(5):311–318
Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH (1993) Carbon monoxide: a putative neural messenger. Science 259(5093):381–384
Von Burg R (1999) Carbon monoxide. J Appl Toxicol 19(5):379–386
Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI (1997) Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 100(3):589–596
Wallace JL, Ianaro A, Flannigan KL, Cirino G (2015) Gaseous mediators in resolution of inflammation. Semin Immunol 27(3):227–233
Wang R (1998) Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor. Can J Physiol Pharmacol 76(1):1–15
Wang R (2014) Gasotransmitters: growing pains and joys. Trends Biochem Sci 39(5):227–232
Wang R, Wu L, Wang Z (1997) The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pflugers Arch 434(3):285–291
Wang R, Wang Z, Wu L, Hanna ST, Peterson-Wakeman R (2001) Reduced vasorelaxant effect of carbon monoxide in diabetes and the underlying mechanisms. Diabetes 50(1):166–174
Wang Z, Wu Y, Zhang S, Zhao Y, Yin X, Wang W, Ma X, Liu H (2019) The role of NO-cGMP pathway inhibition in vascular endothelial-dependent smooth muscle relaxation disorder of AT1-AA positive rats: protective effects of adiponectin. Nitric Oxide 87:10–22
Wegiel B, Gallo DJ, Raman KG, Karlsson JM, Ozanich B, Chin BY, Tzeng E, Ahmad S, Ahmed A, Baty CJ, Otterbein LE (2010) Nitric oxide–dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation 121(4):537–548
Wegiel B, Gallo D, Csizmadia E, Harris C, Belcher J, Vercellotti GM, Penacho N, Seth P, Sukhatme V, Ahmed A, Pandolfi PP, Helczynski L, Bjartell A, Persson JL, Otterbein LE (2013) Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Res 73(23):7009–7021
Wen L, Feil S, Wolters M, Thunemann M, Regler F, Schmidt K, Friebe A, Olbrich M, Langer H, Gawaz M, de Wit C, Feil R (2018) A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis. Nat Commun 9(1):4301
Wobst J, Kessler T, Dang TA, Erdmann J, Schunkert H (2015) Role of sGC-dependent NO signalling and myocardial infarction risk. J Mol Med (Berl) 93(4):383–394
Wu L, Wang R (2005a) Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57(4):585–630
Wu L, Wang R (2005b) Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57(4):585–630
Wu L, Wang R (2006) Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57(4):585–630
Xi Q, Tcheranova D, Parfenova H, Horowitz B, Leffler CW, Jaggar JH (2004) Carbon monoxide activates KCa channels in newborn arteriole smooth muscle cells by increasing apparent Ca2+ sensitivity of alpha-subunits. Am J Physiol Heart Circ Physiol 286(2):H610–H618
Yarlagadda K, Hassani J, Foote IP, Markowitz J (2017) The role of nitric oxide in melanoma. Biochim Biophys Acta Rev Cancer 1868(2):500–509
Zang Y, Popat KC, Reynolds MM (2018) Nitric oxide-mediated fibrinogen deposition prevents platelet adhesion and activation. Biointerphases 13(6):06E403
Zhao Y, Vanhoutte PM, Leung SW (2015) Vascular nitric oxide: beyond eNOS. J Pharmacol Sci 129(2):83–94
Zheng L, Zhou Z, Lin L, Alber S, Watkins S, Kaminski N, Choi AMK, Morse D (2009) Carbon monoxide modulates α–smooth muscle actin and small proline rich-1a expression in fibrosis. Am J Respir Cell Mol Biol 41(1):85–92
Zhou Z, Song R, Fattman C, Greenhill S, Alber S, Oury T, Choi A, Morse D (2005) Carbon monoxide suppresses bleomycin-induced lung fibrosis, vol 166, pp 27–37
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Deshmukh, R., Harwansh, R.K., Bandyopadhyay, N., Bandopadhyay, S., Kumar, P. (2020). Pharmacology of Gasotransmitters (Nitric Oxide and Carbon Monoxide) and Their Action. In: Kumar, P., Deb, P.K. (eds) Frontiers in Pharmacology of Neurotransmitters. Springer, Singapore. https://doi.org/10.1007/978-981-15-3556-7_17
Download citation
DOI: https://doi.org/10.1007/978-981-15-3556-7_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-3555-0
Online ISBN: 978-981-15-3556-7
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)